Literature DB >> 10229096

Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.

J Zimmer1, L Donato, D Hanau, J P Cazenave, A Moretta, M M Tongio, H de la Salle.   

Abstract

We studied HLA class I expression and susceptibility to lysis of activated autologous NK cells in normal and TAP-deficient fibroblasts. These cells were cultured in the presence or absence of cytokines known to increase the surface expression of HLA class I molecules. All the cytokines tested (IFN-alpha, IFN-gamma, TNF-alpha and IFN-gamma + TNF-alpha) increased the expression of HLA class I molecules on fibroblasts after 48-h culture, but on TAP-deficient cells this expression remained very low as compared to that of normal cells. In the presence of IFN-alpha, IFN-gamma or IFN-gamma + TNF-alpha, normal target cells became resistant to lysis by autologous NK cells, whereas this effect was much less pronounced in the case of TAP-deficient fibroblasts. Addition of an anti-HLA class I mAb to fibroblasts treated with cytokines increased lysis of normal but not of TAP-deficient cells. These results suggest that activated TAP-deficient NK cells are strongly cytotoxic to normal autologous cells and that these cells cannot be efficiently protected by cytokines inducing HLA class I expression. Thus, in human TAP deficiency, activated NK cells may contribute to the progressive lung degradation which characterizes the clinical course of these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229096     DOI: 10.1002/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.

Authors:  N Matamoros; J Milà; M Llano; A Balas; J L Vicario; J Pons; C Crespí; N Martinez; J Iglesias-Alzueta; M López-Botet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

Authors:  H de la Salle; J Zimmer; D Fricker; C Angenieux; J P Cazenave; M Okubo; H Maeda; A Plebani; M M Tongio; A Dormoy; D Hanau
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.

Authors:  H Schultz; S Schinke; J Weiss; V Cerundolo; W L Gross; S Gadola
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

5.  Alessandro Moretta and Transporter Associated With Antigen Processing (TAP) Deficiency: On Giant's Shoulders.

Authors:  Jacques Zimmer
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  Imprint of Initial Education and Loss of Ly49C/I in Activated Natural Killer Cells of TAP1-KO and C57BL/6 Wildtype Mice.

Authors:  Neha D Patil; Olivia Domingues; Cécile Masquelier; Maud Theresine; Oceane Schlienger; Clinton Njinju Amin Asaba; Marine Thomas; Carole Seguin-Devaux; Hortense Slevogt; Markus Ollert; Jacques Zimmer
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

7.  Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.

Authors:  Jacques Zimmer; Huguette Bausinger; Emmanuel Andrès; Lionel Donato; Daniel Hanau; François Hentges; Alessandro Moretta; Henri de la Salle
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240

8.  Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Authors:  Mathieu Amand; Gilles Iserentant; Aurélie Poli; Marwan Sleiman; Virginie Fievez; Isaura Pilar Sanchez; Nicolas Sauvageot; Tatiana Michel; Nasséra Aouali; Bassam Janji; Claudia Milena Trujillo-Vargas; Carole Seguin-Devaux; Jacques Zimmer
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

9.  Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface.

Authors:  Zeynep Hein; Britta Borchert; Esam Tolba Abualrous; Sebastian Springer
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.